Diabetes and Endocrinology

Welcome Message

We are pleased to welcome you to the 7^th Annual Summit on Diabetes and Endocrinology (Diabetes Meet 2027), taking place on March 23–24, 2027, in Paris, France, under the theme Advances and Future Directions in Diabetes and Endocrinology. The conference will bring together clinicians, researchers, healthcare professionals, academicians, and students to share their research, clinical experience, and knowledge.

The meeting is dedicated to raising awareness and supporting education in diabetes and endocrinology, while providing a platform for professionals to present their work, exchange knowledge, and discuss current approaches in clinical practice. Whether participants wish to present their research, gain knowledge, listen to scientific presentations, or exchange ideas with colleagues, the conference will provide opportunities for learning, discussion, and professional interaction.

We look forward to welcoming you to Paris for two days of scientific presentations, discussion, and knowledge exchange. Diabetes Meet 2027 will bring together different perspectives and provide a setting for meaningful discussions and continued learning in diabetes and endocrinology.

About Conference

The 7^th Annual Summit on Diabetes and Endocrinology (Diabetes Meet 2027) will be held on March 23–24, 2027, in Paris, France, under the theme Advances and Future Directions in Diabetes and Endocrinology. The meeting will focus on current developments in diabetes and endocrine medicine, with particular attention to diagnosis, treatment, prevention, and patient care. The scientific program will include keynote lectures, oral presentations, poster presentations, workshops and panel discussions.

Diabetes Meet 2027 will be conducted in both in-person and virtual formats, allowing professionals and students from different regions to participate in the scientific program. Participants will have the opportunity to present their research, listen to scientific presentations, exchange knowledge, and discuss clinical experiences with colleagues.

Renowned speakers will present their research findings, clinical experience, and perspectives, while delegates will have opportunities to engage in scientific sessions, interact with experts, network with colleagues, and exchange ideas. Delegates will also have the opportunity to ask questions and learn from specialists working across different areas of diabetes and endocrinology. Those presenting their research will receive an appropriate certificate of presentation, while delegates will receive a certificate of participation from the organizing committee. Outstanding contributions to the scientific program may also be recognized through conference awards, according to the criteria established by the organizing committee.

Featured at Diabetes Meet 2027

• Keynote & Plenary Sessions: Presentations covering important developments in diabetes and endocrinology.
• Scientific Sessions: Discussions on current research, diagnosis, treatment, and patient care.
• Workshops: Practical sessions addressing clinical approaches and selected areas of diabetes and endocrine medicine.
• Symposium: Focused discussions on specific topics in diabetes, endocrinology, and metabolic health.
• Oral Presentations: Researchers and healthcare professionals can present their recent findings and clinical work.
• Poster Presentations: An opportunity to present research and discuss findings with other participants.
• Young Researchers’ Forum: A dedicated platform for students and early-career researchers to present their work and exchange ideas.
• Research Excellence Award: Recognition for notable contributions to diabetes and endocrinology research.
• Best Poster Award: Recognition for selected poster presentations based on scientific quality and presentation.
• Young Scientist Award: Recognition of promising research contributions from early-career scientists.

Join us at Diabetes Meet 2027 to share research, discuss clinical experience, and exchange knowledge across the fields of diabetes and endocrinology.

Why Attend

Diabetes Meet 2027 provides an opportunity to learn about current developments in diabetes and endocrinology and exchange knowledge with professionals involved in clinical practice and research. The program will cover diabetes diagnosis and management, medications and treatment, diabetes complications, obesity and metabolic health, as well as thyroid, pituitary, adrenal, parathyroid, reproductive, and pediatric endocrine disorders. It will also address areas such as diabetes technology, glucose monitoring, genetics, precision medicine, nutrition, and preventive care.

The two-day meeting will provide a setting to present research, share clinical experience, and discuss current approaches with clinicians, researchers, healthcare professionals, academics, and students. Participants can learn from scientific presentations, take part in discussions, ask questions, and exchange knowledge with colleagues from different areas of diabetes and endocrinology through in-person and virtual participation.

Target Audience

• Endocrinologists
• Diabetologists
• Internal Medicine Physicians
• General Practitioners and Family Medicine Physicians
• Pediatric Endocrinologists
• Reproductive Endocrinologists
• Endocrine Surgeons
• Diabetes Specialists and Diabetes Educators
• Obesity and Metabolic Health Specialists
• Thyroid Specialists
• Gynecologists and Obstetricians
• Nephrologists
• Cardiologists
• Ophthalmologists
• Nutritionists and Dietitians
• Pharmacists and Pharmacologists
• Nurses and Allied Healthcare Professionals
• Laboratory and Diagnostic Professionals
• Geneticists and Molecular Researchers
• Clinical Researchers and Research Scholars
• Academicians and Faculty Members
• Medical and Healthcare Students
• Early-Career Researchers
• Hospital and Healthcare Administrators
• Healthcare Organizations and Institutions
• Pharmaceutical and Medical Technology Professionals
• Professional Medical Associations and Societies
• Other Healthcare Professionals Working in Diabetes and Endocrinology

Abstract Submission and Registration Process

Speakers and researchers from around the world are invited to submit abstracts, full papers, case studies, posters, and e-posters by selecting a relevant topic from the "Call for Abstracts" list or their specific area of research interest.

Abstract Guidelines

• The abstract must not exceed 500 words.
• The title should be written in sentence case.
• Include the full names of the author and co-authors, along with their affiliations.
• Provide a short biography of the author (limited to 150 words) and a photograph.

Review Process

• The Scientific Committee Members will review all submissions.
• Acceptance or feedback notifications will be communicated via email within 24–48 hours of submission.

Publication

• All accepted abstracts will be published in the conference proceedings in the respective journal.

Abstract Submission URL: https://diabetes.annualcongress.com/abstract-submission.php

Registration:

Diabetes Meet 2027 is a scientific meeting focused on current developments in diabetes and endocrinology, including diagnosis, treatment, medications, complications, endocrine disorders, obesity, metabolic health, and related areas of research. The two-day program will provide opportunities to attend scientific presentations, share research, discuss clinical experience, and learn about current approaches in diabetes and endocrine care.

The conference is open to endocrinologists, diabetologists, physicians, researchers, healthcare professionals, academicians, educators, students, and other professionals working or interested in diabetes and endocrinology. Delegates who wish to attend the conference, listen to scientific presentations, learn from experts, and take part in discussions are also welcome to participate without presenting a research paper or abstract. Registration options will be available for both in-person and virtual participation, with a separate registration category for virtual attendees. Hotel packages will also be available for participants attending the conference in person.

How to Register

Visit the Registration Page to review the available registration categories and participation options. Choose the option that suits your preferred mode of participation and complete the registration process online.

For any questions or issues regarding registration, participation, presentation, or accommodation, please contact the Program Manager by email or WhatsApp. Our team will be happy to assist you.

Sessions And Tracks

Track 1: Diabetes Mellitus  

Diabetes mellitus is one of the most common endocrine and metabolic disorders, affecting millions of people worldwide. The increasing number of people living with diabetes highlights the importance of prevention, early diagnosis, and effective long-term management. Advances in clinical research, medications, glucose monitoring, and personalized care have improved diabetes management and helped reduce the risk of complications. Along with medical treatment, healthy lifestyle choices and patient education remain important in supporting better health and quality of life. The condition can affect people at different stages of life and may require different approaches depending on the type of diabetes and individual health needs. This session will focus on current clinical practices, research developments, and approaches that support effective diabetes management and improved patient outcomes.

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Prediabetes
• Monogenic and Secondary Diabetes

Track 2: Endocrinology      

Clinical endocrinology focuses on the diagnosis, treatment, and long-term management of disorders affecting the endocrine system. Hormones play an important role in regulating growth, metabolism, reproduction, and many other essential body functions. Advances in clinical research and diagnostic methods have improved the understanding and management of endocrine disorders, allowing for earlier diagnosis and more appropriate treatment. This session will discuss current approaches to endocrine care, hormone-related conditions, treatment options, and developments in clinical practice that can help improve patient care and quality of life.

• Hormonal Disorders
• Endocrine Emergencies
• Hormone Replacement Therapy
• Endocrine Diagnosis and Treatment
• Precision Endocrinology

Track 3: Diabetes Complications    

Despite improvements in diabetes care, long-term complications remain an important concern for people living with diabetes. Early detection, regular screening, and appropriate treatment can help prevent complications or slow their progression. Better understanding of how diabetes affects different organs has also improved approaches to prevention and long-term care. This session will focus on the recognition, prevention, and management of diabetes-related complications and the clinical approaches used to reduce their impact on patients’ health.

• Microvascular Complications
• Macrovascular Complications
• Diabetic Foot Disorders
• Acute Diabetes Complications
• Prevention and Screening of Diabetes Complications

Track 4: Diabetes and Cardiovascular Health      

Diabetes and cardiovascular disease are closely linked, as high blood glucose levels and other metabolic changes can increase the risk of heart and blood vessel problems. Managing blood sugar, blood pressure, cholesterol, and other risk factors is important for protecting cardiovascular health in people with diabetes. Early assessment and appropriate management can help reduce cardiovascular risk and support better long-term health. The topic covers the relationship between diabetes and heart disease, approaches to prevention and diagnosis, and current treatment strategies for managing cardiovascular risk in people with diabetes.

• Diabetes and Heart Disease
• Hypertension and Diabetes
• Dyslipidemia and Cardiovascular Risk
• Atherosclerotic Cardiovascular Disease
• Cardiovascular Risk Assessment and Prevention

Track 5: Diabetic Kidney Disease

Diabetic kidney disease is a common complication of diabetes and can develop gradually, often without clear symptoms in the early stages. High blood glucose and blood pressure can damage the kidneys over time, making regular screening and early management important. Monitoring kidney function and urinary changes can help identify the condition before significant damage occurs. Proper control of blood sugar, blood pressure, and other risk factors can help slow disease progression and reduce the risk of kidney failure. This session focuses on current approaches to screening, diagnosis, treatment, and long-term care of people with diabetes-related kidney disease.

• Diabetic Nephropathy
• Chronic Kidney Disease in Diabetes
• Albuminuria and Kidney Function
• Screening and Early Detection
• Prevention and Management of Kidney Disease

Track 6: Diabetic Neuropathy and Retinopathy

Diabetic neuropathy and retinopathy are common complications that can affect people who have diabetes for many years. High blood sugar can gradually damage nerves and the small blood vessels that supply the eyes, leading to problems with sensation, movement, and vision. Regular screening and good control of blood sugar, blood pressure, and other risk factors can help detect these complications early and reduce their impact. Early treatment and continued follow-up are important for protecting nerve and eye health and maintaining good health.

• Peripheral and Autonomic Neuropathy
• Diabetic Retinopathy
• Diabetic Macular Edema
• Neuropathy Screening and Management
• Eye Screening and Treatment

Track 7: Diabetes Technology and Digital Health

Technology has become an important part of diabetes care, helping people monitor their condition and manage their treatment more effectively. Devices such as continuous glucose monitors and insulin pumps provide useful information that can support day-to-day decisions and improve glucose management. Mobile applications, remote monitoring, and digital health tools also make it easier for patients and healthcare professionals to follow progress and communicate about care. This topic will cover the use of current technologies in diabetes management and how digital tools are being incorporated into routine clinical practice.

• Continuous Glucose Monitoring (CGM)
• Insulin Pumps and Automated Insulin Delivery
• Glucose Monitoring Devices
• Mobile Health Applications
• Remote Patient Monitoring

Track 8: Diabetes in Ageing

Diabetes can become more difficult to manage as people get older because of changes in health, medication use, physical activity, and daily routines. Older adults may also have other health conditions that can affect diabetes management and increase the risk of complications. Treatment therefore needs to consider the person’s overall health, daily needs, and quality of life, rather than focusing only on blood glucose levels. This topic will cover diabetes management in older adults, prevention of complications, medication use, nutrition, and the importance of regular monitoring and support.

• Diabetes in Older Adults
• Age-Related Changes in Diabetes Management
• Medication Management
• Prevention of Hypoglycemia
• Nutrition and Physical Activity in Older Adults

Track 9: Diabetes Nursing and Patient Care

Nurses play an important role in supporting people with diabetes throughout their treatment and daily care. Good patient education can help people understand their condition, follow their treatment plan, monitor blood glucose, and make appropriate lifestyle choices. Regular support and communication can also help with the early identification of problems and improve long-term diabetes management. Nurses also help patients understand their medications, recognize warning signs, and manage diabetes safely at home. Ongoing guidance and follow-up can help patients feel more confident in managing their condition and maintaining their health. This topic will focus on nursing care, patient education, self-management, monitoring, and practical approaches that support better care for people living with diabetes.

• Diabetes Nursing Care
• Patient Education and Self-Management
• Blood Glucose Monitoring
• Medication and Insulin Support
• Lifestyle and Dietary Guidance

Track 10: Obesity and Metabolic Syndrome

Obesity and metabolic syndrome are closely linked to diabetes and other long-term health problems. Excess body weight, high blood pressure, abnormal cholesterol levels, and high blood sugar can occur together and increase the risk of cardiovascular disease and other complications. Early recognition and appropriate management of these risk factors can help improve overall health and reduce the risk of developing diabetes. A balanced diet, regular physical activity, and suitable medical treatment can play an important role in weight and metabolic health. This topic will cover current approaches to prevention, assessment, and management of obesity and metabolic syndrome.

• Obesity and Diabetes
• Metabolic Syndrome
• Weight Management
• Nutrition and Physical Activity
• Medical Management of Obesity

Track 11: Lipid Disorders and Dyslipidemia

Lipid disorders and dyslipidemia are common in people with diabetes and can increase the risk of heart disease and other vascular complications. Abnormal levels of cholesterol and triglycerides may develop due to metabolic changes, lifestyle factors, or other health conditions. Regular lipid testing and appropriate management can help reduce cardiovascular risk and support better long-term health. Treatment may include changes in diet and physical activity, along with medicines when needed. This topic will cover the assessment, prevention, and management of lipid disorders, with a focus on their relationship with diabetes and cardiovascular health.

• Cholesterol and Triglyceride Disorders
• Dyslipidemia in Diabetes
• LDL and HDL Cholesterol
• Cardiovascular Risk
• Lipid-Lowering Therapy

Track 12: Nutrition and Lifestyle Medicine

Nutrition and lifestyle play an important role in preventing and managing diabetes and other metabolic conditions. A balanced diet, regular physical activity, healthy sleep, and other daily habits can help improve blood glucose levels, body weight, and overall health. Lifestyle changes can also support the management of cardiovascular risk factors and reduce the chance of developing long-term complications. This session will cover practical approaches to healthy eating, physical activity, weight management, and lifestyle changes that can be included in everyday diabetes care.

• Medical Nutrition Therapy
• Healthy Eating and Meal Planning
• Physical Activity and Exercise
• Weight Management
• Lifestyle Changes in Diabetes
• Behavioral Approaches to Healthy Living

Track 13: Advances in Diabetes Treatment

Treatment for diabetes continues to develop, giving patients and healthcare professionals more options for managing blood glucose and reducing the risk of complications. Along with insulin and other established medicines, newer therapies have improved treatment choices for different types of diabetes and patient needs. Treatment decisions increasingly consider blood glucose levels, cardiovascular and kidney health, body weight, lifestyle, and other individual factors. Better understanding of how different treatments work has also helped clinicians select therapies according to each person’s needs and health status. Ongoing research continues to evaluate the safety, effectiveness, and long-term benefits of newer treatment options. This topic will cover recent developments in diabetes medicines, insulin therapy, combination treatments, and approaches to improving long-term diabetes care.

• Insulin Therapy
• Oral Antidiabetic Medications
• GLP-1 Receptor Agonists
• SGLT2 Inhibitors
• Combination and Emerging Therapies
• Personalized Diabetes Treatment

Track 14: Thyroid Disorders

Thyroid disorders are among the most common endocrine conditions and affect millions of people worldwide. The thyroid plays an important role in regulating metabolism, growth, cardiovascular function, and overall health. Early diagnosis and appropriate treatment are important for preventing complications and maintaining good health. Advances in laboratory testing, imaging, medical treatment, and surgical care have improved the diagnosis and management of thyroid diseases. This session will cover current clinical approaches, research developments, and treatment options for common and complex thyroid disorders.

• Hypothyroidism
• Hyperthyroidism
• Hashimoto’s Thyroiditis and Graves’ Disease
• Thyroid Nodules and Goiter
• Thyroid Cancer

Track 15: Pituitary and Hypothalamic Disorders

The pituitary gland and hypothalamus play an important role in controlling many hormonal functions, including growth, metabolism, reproduction, thyroid activity, and the body’s response to stress. Disorders affecting these areas can lead to changes in hormone production and may affect several body systems. Accurate diagnosis often requires careful clinical assessment, hormone testing, and appropriate imaging. Advances in diagnostic methods and treatment have improved the management of these conditions and helped support better long-term care.

• Pituitary Adenomas
• Growth Hormone Disorders
• Disorders of Prolactin
• Hypopituitarism
• Diabetes Insipidus and Water Balance Disorders

Track 16: Adrenal Disorders

The adrenal glands produce hormones that are important for regulating blood pressure, metabolism, stress responses, and fluid and electrolyte balance. Disorders of the adrenal glands can result from excessive or insufficient hormone production and may affect several aspects of health. Advances in hormone testing, imaging, and medical and surgical treatment have improved the assessment and management of adrenal disorders. This session will cover common adrenal conditions, their diagnosis, treatment, and long-term management.

• Adrenal Insufficiency
• Cushing’s Syndrome
• Primary Aldosteronism
• Pheochromocytoma and Paraganglioma
• Adrenal Incidentalomas

Track 17: Parathyroid Disorders

The parathyroid glands play an important role in maintaining the body’s calcium and phosphate balance, which is essential for healthy bones, muscles, and normal nerve function. Disorders of the parathyroid glands can lead to abnormal calcium levels and may affect bone health, kidney function, and other body systems. Early diagnosis and appropriate management are important to prevent long-term complications. Advances in laboratory testing, imaging, and treatment options have improved the assessment and care of people with parathyroid disorders.

• Primary Hyperparathyroidism
• Secondary Hyperparathyroidism
• Hypoparathyroidism
• Calcium and Phosphate Disorders
• Parathyroid Tumors and Adenomas

Track 18: Paediatric Endocrinology

Paediatric endocrinology focuses on hormonal and metabolic conditions that affect children and adolescents. Hormones play an important role in normal growth, development, puberty, metabolism, and overall health. Endocrine conditions during childhood can have an effect on physical development and may require ongoing assessment as children grow Treatment and follow-up may vary depending on the child’s age, growth, stage of development, and individual needs. This session will cover common paediatric endocrine disorders and current approaches to their diagnosis and management.

• Childhood Diabetes
• Growth and Growth Hormone Disorders
• Disorders of Puberty
• Paediatric Thyroid Disorders
• Childhood Obesity
• Congenital Endocrine Disorders

Track 19: Reproductive Endocrinology and Women’s Health

Reproductive endocrinology focuses on the role of hormones in fertility, menstrual health, pregnancy, and reproductive function. Hormonal changes and endocrine conditions can affect women at different stages of life and may influence ovarian function, menstrual cycles, and fertility. The field includes conditions involving hormonal imbalance, reproductive function, and pregnancy-related endocrine changes. It also considers the relationship between reproductive hormones and broader aspects of women’s health.

• Polycystic Ovary Syndrome (PCOS)
• Infertility and Assisted Reproductive Technologies
• Menstrual and Ovulatory Disorders
• Menopause and Hormone Therapy
• Endocrine Disorders in Pregnancy
• Reproductive Hormonal Disorders

Track 20: Male Endocrinology

Male endocrinology focuses on hormonal conditions that affect men’s reproductive health, metabolism, sexual function, and overall well-being. Testosterone and other hormones play important roles in reproductive development, fertility, muscle and bone health, and body composition. Hormonal changes can occur at different stages of life and may be associated with conditions affecting reproductive and metabolic health. Current clinical approaches include hormone assessment, appropriate diagnosis, and treatment based on the underlying condition and the person’s needs.

• Testosterone Deficiency
• Male Infertility
• Androgen Disorders
• Erectile Dysfunction
• Male Reproductive Hormonal Disorders
• Hormone Replacement Therapy

Track 21: Bone and Mineral Metabolism

Bone and mineral metabolism is an important part of endocrinology, involving the regulation of calcium, phosphate, vitamin D, and hormones that help maintain healthy bones. Changes in these processes can affect bone strength, mineral levels, and overall skeletal health. Conditions such as osteoporosis and disorders of calcium and phosphate balance are common concerns, particularly with ageing and certain endocrine diseases. Current research and clinical practice focus on understanding these conditions, assessing fracture risk, and selecting appropriate treatment and long-term management.

• Osteoporosis
• Vitamin D Deficiency
• Calcium and Phosphate Disorders
• Hypercalcemia and Hypocalcemia
• Metabolic Bone Diseases
• Fracture Prevention and Bone Health

Track 22: Endocrine Oncology

Endocrine oncology focuses on tumors that develop in hormone-producing glands and tissues, including the thyroid, adrenal glands, pituitary gland, and neuroendocrine system. These tumors may affect hormone production and can vary in their behavior and clinical features. Their evaluation may involve hormone testing, imaging, pathology, and molecular assessment to determine the type and characteristics of the tumor. Treatment options depend on the type and stage  of the condition and may include surgery, medication, radiation therapy, or other specialized treatments. The field also includes the study of endocrine tumor biology, diagnosis, treatment, and long-term follow-up.

• Thyroid Cancer
• Adrenal Tumors
• Pituitary Tumors
• Neuroendocrine Tumors
• Multiple Endocrine Neoplasia (MEN)
• Endocrine Tumor Diagnosis and Management

Track 23: Advances in Endocrine Treatment

Treatment of endocrine disorders has developed with a better understanding of hormones, disease mechanisms, and patient needs. New medicines, improved diagnostic methods, and advances in surgical care have provided more treatment options for a range of hormonal disorders. The choice of treatment can depend on the type of condition, hormone levels, symptoms, age, and overall health. Regular monitoring can help healthcare professionals assess how well a treatment is working and make changes when necessary. Research also continues to examine new medicines and treatment approaches for endocrine conditions. The topic covers medical and surgical treatments used in endocrinology and recent developments in clinical practice.

• Hormone Replacement Therapy
• Medical Treatment of Endocrine Disorders
• Endocrine Surgery
• Targeted Therapies
• New and Emerging Endocrine Treatments
• Personalized Endocrine Care

Track 24: Current Research and Innovations in Diabetes and Endocrinology

Research in diabetes and endocrinology continues to expand knowledge of disease mechanisms, diagnosis, treatment, and long-term care. Current studies cover areas such as clinical medicine, genetics, medications, diagnostic methods, and healthcare technologies. Research is also examining earlier disease detection, treatment selection, and the long-term effects of diabetes and endocrine disorders. Clinical trials and translational research help evaluate new findings and their application in healthcare. This topic will cover recent research findings, ongoing studies, and developments in clinical practice across diabetes and endocrinology.

• Clinical Research in Diabetes and Endocrinology
• New Diagnostic Approaches
• Emerging Therapeutic Strategies
• Genetics and Molecular Research
• Clinical Trials and Translational Research
• Recent Developments in Patient Care

Track 25: Artificial Intelligence and Future Innovations in Diabetes and Endocrinology      

Artificial intelligence and emerging technologies are becoming increasingly relevant to diabetes and endocrinology. AI-based tools can assist with data analysis, risk assessment, glucose monitoring, clinical decision support, and patient management. Digital systems and machine learning methods are also being studied for their potential use in identifying patterns in health data and supporting clinical decision-making. Research in this field is examining how these technologies can be evaluated and responsibly incorporated into clinical practice. This session will cover current applications of artificial intelligence, emerging technologies, and ongoing research in diabetes and endocrinology.

• Artificial Intelligence in Diabetes Care
• AI-Based Clinical Decision Support
• Machine Learning and Predictive Analytics
• Digital Health and Remote Monitoring
• Wearable Technologies and Smart Devices
• Emerging Technologies in Endocrinology 

Market Analysis

The 7^th Annual Summit on Diabetes and Endocrinology (Diabetes Meet 2027) will provide a platform to discuss important developments in diabetes care, including advances in monitoring technologies, treatment approaches, digital health, and personalized patient care. The growing need for effective diabetes management is also creating opportunities for innovation in medical devices and healthcare technologies.

Global Diabetes Devices Market

The global diabetes devices market is experiencing steady growth, driven by the increasing prevalence of diabetes and the growing need for effective monitoring and treatment solutions. Rising awareness of diabetes management, along with greater emphasis on early detection and regular glucose monitoring, is encouraging the use of diabetes devices across different healthcare settings. The increasing number of people living with diabetes, particularly in developing regions, is also contributing to market demand.

Technological developments are further supporting market growth. Continuous glucose monitoring systems, insulin pumps, smart insulin pens, blood glucose meters, and connected diabetes devices are providing more convenient ways to monitor and manage diabetes. The integration of these technologies with mobile applications, wearable devices, and digital health platforms is also supporting real-time monitoring and more personalized approaches to diabetes care.

The market is expected to continue expanding as healthcare providers, governments, and medical technology companies invest in diabetes prevention, awareness, and innovative treatment solutions. Asia-Pacific and other emerging markets are expected to offer significant opportunities due to the rising prevalence of diabetes, expanding healthcare infrastructure, and increasing adoption of modern medical technologies. These developments closely align with the conference focus on the advances and future directions in diabetes and endocrinology.

Participation / Presentation

Diabetes Meet 2027 welcomes researchers, clinicians, healthcare professionals, academicians, and students to participate in the scientific program through oral presentations, keynote presentations, workshops, poster presentations, e-poster presentations, and virtual presentations. Participants may choose the format that best suits their research, professional experience, and availability.

Oral Presentation

Oral presentations are open to research-based, clinical, theoretical, and professional topics related to diabetes, endocrinology, metabolism, and related areas of healthcare. Presenters can share research findings, clinical experience, case studies, and current approaches in their respective fields.

Speaker Presentation: 30 minutes, including presentation and moderated Q&A
Keynote Presentation: 40–45 minutes, including discussion

Workshop Presentation

Workshops will focus on practical and clinical aspects of diabetes and endocrinology. Topics may include diabetes management, endocrinology, treatment approaches, clinical practices, diagnostic methods, and the use of technology in patient care.

Duration: 45–50 minutes

Interactive sessions and case-based discussions will be included where appropriate to encourage participation and discussion among attendees.

Poster Presentation

Poster presentations are open to students, researchers, clinicians, and healthcare professionals who wish to present their research or clinical work in diabetes and endocrinology.

Presentation Time: 20 minutes, including Q&A

• Presenters should follow the conference poster guidelines.
• The poster should be prepared according to the specified format and dimensions.
• Questions may be asked by the scientific committee or session moderators.

E-Poster Presentation

E-poster presentations provide an option for participants who prefer to present their work electronically. Accepted e-posters will be displayed as part of the conference scientific program and will be available for viewing by participants during the meeting.

Duration: 10 minutes

Virtual / Webinar Presentation

Participants who are unable to attend the conference in person may choose the virtual presentation option. Presentations may be delivered online or submitted as a pre-recorded presentation, subject to the conference presentation guidelines.

Exhibition

The exhibition will provide space for organizations working in diabetes, endocrinology, diagnostics, pharmaceuticals, medical technology, digital health, and related healthcare services to present their products, services, and professional information.

Exhibitors may include:

• Diabetes Technology Companies
• Continuous Glucose Monitoring (CGM) Manufacturers
• Insulin Delivery System Providers
• Pharmaceutical and Biotechnology Companies
• Hospitals and Healthcare Organizations
• Diagnostic Equipment and Laboratory Companies
• Digital Health and AI Companies
• Clinical Research Organizations
• Academic and Research Institutions

For exhibition inquiries: diabetes@memeetings.com

Sponsorship & Advertisement

Sponsorship and advertisement opportunities will be available for organizations interested in supporting the conference or presenting information about their products and services to participants.

For sponsorship and advertisement details, please contact: diabetes@memeetings.com

Communication Instructions

Please add diabetes@memeetings.com to your safe-sender or contact list to receive conference-related communication.

• If you do not receive a confirmation within 48 hours after registration or an inquiry, please contact the conference team.
• Please check your spam or junk folder before contacting the team again.
• Include your mobile number when submitting registration or abstract details so that the team can contact you if clarification is required.

Group Registration

Group registration options are available for institutions, organizations, research groups, and other groups of participants. For information about group registration and applicable rates, please contact the registration team at diabetes@memeetings.com.

Important Presentation Information

• Abstracts should be submitted through the official abstract submission process.
• Accepted presenters will receive presentation guidelines and submission instructions.
• Presentation files should be submitted within the specified deadline.
• Presenters should follow the allotted time for their respective presentation category.

Visa Assistance for Attendees

Planning a Trip to Paris, France? Attend Our Meeting!

We are pleased to assist international participants with the visa application process. To support attendees in obtaining their visas, we provide the following official visa support documents:

• Official Letter of Invitation (Visa Letter)
• Official Abstract Acceptance Letter (for presenters)
• Receipt of Payment

Important Notes

• The Visa Letter (Official Letter of Invitation) will be issued only after successful conference registration and payment for the conference.
• Visa Letters will be provided exclusively to participants who have been officially accepted to attend the conference.

How to Request a Visa Letter

To request your Visa Letter, please contact the Program Manager, Ms. Laura Smith, via:

• Email: diabetes@memeetings.com
• WhatsApp: +44 7735038467

When requesting the Visa Letter, kindly provide the following details:

• Full name (as shown on your passport)
• Scanned copy of your passport (showing passport number and date of birth)
• Abstract Acceptance Letter (for presenters)

Payment Methods:

Registration payments can be completed through:

• Online Payment Gateway (Stripe)
• Bank-to-Bank Transfer

If you experience any issues during Registration or payment, please contact Ms. Laura Smith via email at diabetes@memeetings.com or through WhatsApp at +44 7735038467. The Diabetes Meet 2027 team will issue an official invoice to facilitate Bank-to-Bank Transfers if required.

We look forward to welcoming you to the 7th Annual Summit on Diabetes and Endocrinology (Diabetes Meet 2027) on March 23–24, 2027, in Paris, France, and to providing you with the necessary support throughout your participation.